Invenomic Capital Management’s IQVIA IQV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.55M Sell
23,551
-5,308
-18% -$926K 0.27% 89
2026
Q1
$4.92M Buy
+28,859
New +$5.63M 0.23% 104
2025
Q4
– Sell
-57,248
Closed -$10.9M – 160
2025
Q3
$10.9M Sell
57,248
-70,034
-55% -$12.7M 0.53% 69
2025
Q2
$20.1M Buy
127,282
+39,220
+45% +$5.9M 1.14% 31
2025
Q1
$15.5M Buy
88,062
+34,913
+66% +$6.77M 0.78% 44
2024
Q4
$10.4M Buy
+53,149
New +$11.2M 0.5% 59

Other funds holding IQV

Invenomic Capital Management's IQV Position: Q2 2026 in Review

Invenomic Capital Management reduced its IQVIA (IQV) stake by 18% in Q2 2026, selling an estimated $926K and leaving 23,551 shares worth $4.55M. The position accounts for 0.27% of the portfolio, ranked #89.

Invenomic Capital Management first reported a position in IQV in Q4 2024 and has held it in 6 quarters since. The position peaked at $20.1M in Q2 2025. 1,091 funds tracked by Wall St. Rank hold IQV as of Q2 2026.

  • Invenomic Capital Management held 23,551 shares of IQVIA worth $4.55M as of Q2 2026.
  • Invenomic Capital Management sold 5,308 IQVIA shares in Q2 2026, an estimated $926K.
  • IQVIA made up 0.27% of Invenomic Capital Management's portfolio in Q2 2026, its #89 holding.
  • Invenomic Capital Management first reported a position in IQVIA in Q4 2024 and has held it in 6 quarters since.
  • Invenomic Capital Management's IQVIA position peaked at $20.1M in Q2 2025.
  • 1,091 funds tracked by Wall St. Rank held IQVIA as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.